老年人房颤认知障碍与治疗策略:SAGE-AF研究
SAGE-AF为前瞻性观察性队列研究,纳入972例老年房颤患者,按临床治疗分为率控制组408例与节律控制组564例,随访2年。校正基线差异后,率控制组2年内认知受损风险约为节律控制组的1.5倍,认知功能下降更明显,但衰弱状态两组无差异。
要点
- 老年房颤患者率控制策略与2年认知功能下降风险升高相关。
- 率控制组基线年龄更大、持续性房颤及基线认知障碍比例更高。
- 两种治疗策略间衰弱状态变化未见差异。
核心结论
- 在完成2年随访的非随机观察性队列中,老年房颤患者选择率控制与认知功能下降风险增加相关,但与衰弱无关。
研究设计与样本
- SAGE-AF为前瞻性观察性队列研究,2016至2018年纳入老年房颤患者并纵向随访2年。
- 共972例完成基线检查与2年随访,平均年龄75岁(SD=6.8),49%为女性,87%为非西班牙裔白人。
- 按入组时临床治疗非随机分为率控制组408例(42%)与节律控制组564例(58%)。
- 采用蒙特利尔认知评估量表与Fried衰弱表型评估认知功能与衰弱状态,并用纵向二分类混合模型比较。
- 原文未报告研究机构、资金来源与具体纳入排除标准。
主要发现
- 率控制组患者年龄更大,更常有持续性房颤、既往卒中、华法林治疗及基线认知障碍。
- 校正基线差异后,率控制组2年内认知受损的校正OR为1.47(95%CI:1.12,1.98)。
- 率控制组认知功能下降更明显,校正估计值为-0.59(0.23),p<0.01。
- 衰弱状态在两种治疗策略间未见差异。
关键数值与推荐
- 认知受损以蒙特利尔认知评估量表评定,衰弱以Fried衰弱表型工具评定。
- 原文未报告认知受损的具体评分阈值、衰弱判定切点及随访评估时间间隔。
临床怎么用
- 对老年房颤患者制定率或节律控制策略时,应将认知功能下降风险纳入共同决策。
- 基线认知障碍者可能更倾向被选择率控制,解读关联时需注意适应证混杂。
- 随访中可同步关注认知功能变化,衰弱管理不应仅依据房颤治疗策略。
- 原文为观察性研究,不能据此推断率控制导致认知下降。
局限性
- 为非随机观察性队列,治疗分组存在适应证混杂,基线两组特征不同。
- 仅972例完成2年随访,可能存在失访偏倚。
- 人群以非西班牙裔白人为主,外推需谨慎。
- 原文未报告多中心设计、失访比例及残余混杂控制细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cognitive impairment is strongly associated with atrial fibrillation (AF). Rate and rhythm control are the two treatment strategies for AF and the effect of treatment strategy on risk of cognitive decline and frailty is not well established. We sought to determine how treatment strategy affects geriatric-centered outcomes. METHODS: The Systematic Assessment of Geriatric Elements-AF (SAGE-AF) was a prospective, observational, cohort study. Older adults with AF were prospectively enrolled between 2016 and 2018 and followed longitudinally for 2 years. In a non-randomized fashion, participants were grouped by rate or rhythm control treatment strategy based on clinical treatment at enrollment. Baseline characteristics were compared. Longitudinal binary mixed models were used to compare treatment strategy with respect to change in cognitive function and frailty status. Cognitive function and frailty status were assessed with the Montreal Cognitive Assessment Battery and Fried frailty phenotype tools. RESULTS: 972 participants (mean age = 75, SD = 6.8; 49% female, 87% non-Hispanic white) completed baseline examination and 2-year follow-up. 408 (42%) were treated with rate control and 564 (58%) with rhythm control. The patient characteristics of the two groups were different at baseline. Participants in the rate control group were older, more likely to have persistent AF, prior stroke, be treated with warfarin and have baseline cognitive impairment. After adjusting for baseline differences, participants treated with rate control were 1.5 times more likely to be cognitively impaired over 2 years (adjusted OR: 1.47, 95% CI:1.12, 1.98) and had a greater decline in cognitive function (adjusted estimate: -0.59 (0.23), p < 0.01) in comparison to rhythm control. Frailty did not vary between the treatment strategies. CONCLUSIONS: Among those who had 2-year follow-up in non-randomized observational cohort, the decision to rate control AF in older adults was associated with increased odds of decline in cognitive function but not frailty.
引用
- Athreya DS, Saczynski JS, Gurwitz JH, et al. Cognitive impairment and treatment strategy for atrial fibrillation in older adults: The SAGE-AF study. J Am Geriatr Soc. 2024. PMID: 38742376. doi:10.1111/jgs.18949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。